1Di Pasquale P,Cannizzaro S,Parrinello G,et al.Is delayed facilitated percutaneous coronary intervention better than immediate in reperfused myocardial infarction? Six months follow up findings.J Thromb Thrombolysis,2006,21:147-157. 被引量：1
2Antman EM,Anbe DT,Armstrong PW,et al.ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction—executive summary:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients With Acute Myocardial Infarction).Circulation,2004,110:588-636. 被引量：1
3Harrington RA,Becker RC,Ezekowitz M,et al.Antithrombotic therapy for coronary artery disease:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):513S-548S. 被引量：1
2Abbas AE, Brodie B, Dixon S, et al. Incidence and prognostic incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol,2005 ;96:173 -176. 被引量：1
3Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspiren in patients with acute coronary syndromes without ST - segment elevation. N Engl J Med, 2001 ; 345 ( 7 ) : 494 - 502. 被引量：1
4Ng FH, Wong SY, Chang CM, et al, High incidence of copidogei - associated gastrointestinal bleeding inpatients with previous peptic ulcer disease. Aliment Pharmacol Ther,2003 ; 18 ( 4 ) : 443 - 449. 被引量：1
5Atwater BD, Roe MT, Mahaffey KW. Platelet glycoprotein Ⅱb/Ⅲa receptor antagonists in non - ST segment elevation acute coronary syndromes: areview and guide to patient selection. Drugs, 2005 ;65(3) :313 -324. 被引量：1
6Curran MP, Keating GM. Eptifibatide: a review of its use in patients weth acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs,2005 ; 65 ( 14 ) : 2009 - 2035. 被引量：1
